ArticleInfection2026

Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective.

Johanna Röder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.